Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update

被引：10

作者：

Chellappan, Dinesh Kumar ^{[1
]}

Dharwal, Vivek ^{[2
,3
]}

Paudel, Keshav Raj ^{[2
,3
]}

Jha, Niraj Kumar ^{[4
]}

MacLoughlin, Ronan ^{[5
,6
,7
]}

Oliver, Brian G. ^{[2
,8
]}

M Hansbro, Philip ^{[2
,3
]}

Dua, Kamal ^{[3
,9
]}

机构：

[1] Int Med Univ, Sch Pharm, Dept Life Sci, Kuala Lumpur 57000, Malaysia

[2] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia

[3] Centenary Inst, Ctr Inflammat, Sydney, NSW 2050, Australia

[4] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Plot 32-34,Knowledge Pk 3, Greater Noida 201310, Uttar Pradesh, India

[5] Aerogen, IDA Business Pk, Galway H91 HE94, Ireland

[6] Royal Coll Surgeons Ireland, Sch Pharm & Biomol Sci, Dublin D02 YN77, Ireland

[7] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin D02 PN40, Ireland

[8] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia

[9] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia

来源：

FUTURE MEDICINAL CHEMISTRY | 2021年 / 13卷 / 15期

关键词：

inflammation; mitochondria; respiratory diseases; targeted therapies; INHIBITION; COPD;

D O I：

10.4155/fmc-2021-0097

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1249 / 1251

页数：3

共 50 条

[31] Targeted Therapies in Psoriatic Arthritis-An Update
Sundanum, Sonia
Orr, Carl
Veale, Douglas
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
[32] Targeted therapies for psoriatic arthritis: an update for the dermatologist
Elman, Scott A.
Weinblatt, Michael E.
Merola, Joseph F.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 173 - 181
[33] Update in Systemic and Targeted Therapies in Gastrointestinal Oncology
Yee, Nelson S.
BIOMEDICINES, 2018, 6 (01)
[34] Targeted therapies in inflammatory skin diseases
Bachelez, Herve
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (8-9): : 1939 - 1945
[35] Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics
Zhou, Wen-cheng
Qu, Jiao
Xie, Sheng-yang
Sun, Yang
Yao, Hong-wei
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
[36] Update on Targeted Therapies in Ovarian Cancer (OC)
Sessa, C.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S84 - S84
[37] A WORLDWIDE PHARMACOEPIDEMIOLOGICAL UPDATE OF DRUG-ASSOCIATED ANCA-ASSOCIATED VASCULITIS AT THE TIME OF TARGETED THERAPIES
Deshayes, S.
Dolladille, C.
Dumont, A.
Silva, N. M.
Chretien, B.
De Boysson, H.
Alexandre, J.
Aouba, A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 270 - 270
[38] Biomechanics of T Cell Dysfunctions in Chronic Diseases
Gunasinghe, Sachith D.
Peres, Newton G.
Goyette, Jesse
Gaus, Katharina
FRONTIERS IN IMMUNOLOGY, 2021, 12
[39] Developing therapies for human mitochondrial diseases
Murphy, M.
NEUROMUSCULAR DISORDERS, 2011, 21 : S1 - S1
[40] Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update
Meenu Mehta
Daljeet S. Dhanjal
Keshav R. Paudel
Bhupender Singh
Gaurav Gupta
S. Rajeshkumar
Lakshmi Thangavelu
Murtaza M. Tambuwala
Hamid A. Bakshi
Dinesh K. Chellappan
Parijat Pandey
Harish Dureja
Nitin B. Charbe
Sachin K. Singh
Shakti D. Shukla
Srinivas Nammi
Alaa A. Aljabali
Peter R. Wich
Philip M. Hansbro
Saurabh Satija
Kamal Dua
Inflammopharmacology, 2020, 28 : 795 - 817

← 1 2 3 4 5 →